IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
89 hedge funds and large institutions have $316M invested in IGM Biosciences in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 26 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
11% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 19
35% less capital invested
Capital invested by funds: $487M → $316M (-$172M)
Holders
89
Holding in Top 10
–
Calls
$2M
Puts
$252K
Top Buyers
| 1 | +$6.79M | |
| 2 | +$6.64M | |
| 3 | +$3.51M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$1.28M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$1.1M |
Top Sellers
| 1 | -$10.8M | |
| 2 | -$7.98M | |
| 3 | -$5.75M | |
| 4 |
Goldman Sachs
New York
|
-$4.14M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$3.67M |